Audience: Pharmacists and consumers(May 23, 2003) FDA announced that Albers Medical Distributors, Inc voluntary recalled 3 lots of 10 mg 90-count bottles of the cholesterol-lowering drug Lipitor and is warning healthcare providers and others that these three lots of counterfeit Lipitor represent a potentially significant risk to consumers. FDA's investigation into this matter is continuing.
(June 9, 2003) Albers expanded their original voluntary recall to include all lots of Lipitor that Albers purchased, which were packaged by Med-Pro.
[UPDATE June 9, 2003 - Press Release - Albers Medical Distributors, Inc.] PDF Format
[UPDATE June 3, 2003 - Talk Paper - FDA]
[May 23, 2003 Talk Paper - FDA]
[May 22, 2003 Press Release - Albers Medical Distributors, Inc.]